Pillr Health Company Profile

Background

Overview

Founded in 2003 and headquartered in Boca Raton, Florida, Pillr Health is a leading provider of innovative solutions designed to optimize and streamline pharmacy operations. The company's mission is to transform healthcare by empowering organizations with the tools, expertise, and support needed to thrive in an ever-changing industry, with a particular focus on enhancing efficiency, reducing costs, and improving patient outcomes within the 340B program and beyond.

Industry Significance

Pillr Health has been at the forefront of healthcare innovation, providing comprehensive 340B solutions to healthcare providers. As the industry has evolved, so have we, expanding our offerings and rebranding as Pillr Health to better represent our future-focused approach.

Key Strategic Focus

Core Objectives

Pillr Health's strategic focus centers on delivering comprehensive solutions that empower healthcare organizations to navigate the complexities of the 340B program and pharmacy operations. The company aims to enhance operational efficiency, ensure regulatory compliance, and improve patient outcomes through its suite of services.

Areas of Specialization

The company specializes in:

340B Program Management: Offering third-party administration, auditing services, and consulting to ensure compliance and optimize program performance.

Pharmacy Operations Optimization: Providing technology and services to streamline pharmacy workflows, including inventory management, contract pharmacy administration, and specialty pharmacy development.

Key Technologies Utilized

Pillr Health employs a range of advanced technologies, including:

Cloud-Based Platforms: Enabling real-time data transparency and seamless integration with existing systems.

Advanced Reporting and Analytics: Offering customizable reports and tools for efficient provider and location management.

Primary Markets Targeted

Pillr Health serves a diverse clientele, including:

Health Systems and Hospitals: Assisting in managing complex pharmacy workflows and ensuring 340B program integrity.

Community Health Centers: Supporting CHCs in accessing discounted prescription drugs under the 340B program.

Pharmacies: Providing solutions to optimize operations and enhance patient care.

Financials and Funding

Revenue

As of June 2025, Pillr Health's annual revenue is estimated to be $31.6 million.

Funding History

Specific details regarding Pillr Health's funding history are not publicly disclosed.

Pipeline Development

Pillr Health's pipeline focuses on enhancing and expanding its suite of services to meet the evolving needs of healthcare providers. This includes the development of advanced analytics tools, integration of artificial intelligence for predictive insights, and expansion of consulting services to address emerging challenges in pharmacy operations and 340B program management.

Technological Platform and Innovation

Proprietary Technologies

Pillr Health offers a proprietary, comprehensive turnkey solution that allows Community Health Centers (CHCs) to gain access to significantly discounted prices on prescription drugs under Section 340B of the Public Health Service Act.

Significant Scientific Methods

The company employs advanced reporting and analytics, providing customizable reports, streamlined claims processing, and audit-ready documentation to enhance program performance and compliance.

Leadership Team

Skip Devanny: Chief Executive Officer

Clay Callicoat: Chief Financial Officer

David Wanless: Chief Information Officer

Nick Rebmann: Chief Growth Officer

Mickey Price: Chief Operations Officer

Casey Nelson: Chief Pharmacy Officer

Jonathan Ghenn: Chief Marketing Officer

Marissa Dermer: Senior Vice President, Accounting and Controls

Scott Koeppen: Chief Services Officer

Leadership Changes

As of the latest available information, there have been no recent significant changes or appointments within Pillr Health's leadership team.

Competitor Profile

Market Insights and Dynamics

The 340B program management and pharmacy operations optimization market is characterized by increasing complexity due to evolving regulations and the need for enhanced operational efficiency. Healthcare providers seek comprehensive solutions to navigate these challenges, driving demand for specialized services.

Competitor Analysis

Key competitors in this space include:

Clearway Health: Provides specialty pharmacy services tailored to hospitals and health systems, focusing on program design, medication access, network expansion, and embedded clinical staff.

Kalderos: Offers a drug discount management platform that helps stakeholders monitor and resolve issues related to noncompliant drug discount claims using AI and machine learning.

Macro Helix: Provides software and services for managing 340B drug pricing programs, including split billing, contract pharmacy administration, referral capture, audit preparation, and compliance monitoring.

Strategic Collaborations and Partnerships

Pillr Health has strengthened its market position through strategic acquisitions, including:

RxStrategies: Acquired on February 4, 2025, RxStrategies offers a proprietary, comprehensive turnkey solution that allows Community Health Centers (CHCs) to gain access to significantly discounted prices on prescription drugs under Section 340B of the Public Health Service Act.

Hudson Headwaters 340B: Also acquired on February 4, 2025, Hudson Headwaters 340B provides third-party administration, auditing services, and consulting for 340B programs.

Operational Insights

Pillr Health differentiates itself through a combination of advanced technology, personalized service, and deep industry expertise. The company's cloud-based platforms and advanced analytics tools provide clients with real-time data transparency and actionable insights, while its commitment to exceptional service ensures tailored support for each client.

Strategic Opportunities and Future Directions

Looking ahead, Pillr Health aims to expand its technological capabilities by integrating artificial intelligence and machine learning to provide predictive analytics and enhance decision-making for clients. The company also plans to broaden its service offerings to address emerging challenges in pharmacy operations and 340B program management, positioning itself as a comprehensive partner for healthcare providers.